NxStage(R) Ranked 14th Fastest Growing Company in North America on Deloitte's 2008 Technolog... (ements to differ materially fromanticipa...)

NxStage(R) Ranked 14th Fastest Growing Company in North America on Deloitte's 2008 Technology Fast 500

Date:11/21/2008

ements to differ materially from anticipated results, performance or achievements, including market acceptance and demand for the NxStage System One, growth in home hemodialysis, and certain other factors that may affect future operating results and which are detailed in NxStage's filings with the Securities and Exchange Commission, including its Quarterly Report on Form 10-Q for the quarter ended September 30, 2008. NxStage is under no obligation to (and expressly disclaims any such obligation to) update or alter its forward-looking statements, whether as a result of new information, future events or otherwise.

    Kristen K. Sheppard, Esq.
    VP, Investor Relations
    NxStage Medical, Inc.
    ksheppard@nxstage.com

SOURCE NxStage Medical, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3
Related medicine news :

1. NxStage(R) Achieves Milestone with 3,000 End-Stage Renal Disease Patients Receiving Daily Home Hemodialysis Therapy
2. Emil Paganini, MD, Joins NxStage(R) as Critical Care Medical Advisor
3. NxStage(R) Medical to Report Fourth Quarter & Full Year 2007 Financial Results on Tuesday, February 12th
4. U.S. News & World Report Names Kaiser Permanente Top-Ranked Health Plan in Georgia
5. HTH Worldwide Ranked Number 435 Fastest Growing Company in North America on Deloittes 2008 Technology Fast 500
6. Health Alliance Plans Medicare HMO is Top-Ranked Medicare Plan in Michigan and Top 25 in U.S.
7. Preferred Care Gold Ranked Number One Medicare Advantage Health Plan Nationally In U.S. News & World Report/NCQA Americas Best Health Plans 2008 Listing
8. Health Plan of Michigan Ranked Among Nations Best Medicaid Health Plans in 2008
9. Cadient Group Ranked 34th in Deloittes Fast 50 Program for Greater Philadelphia
10. HTH Worldwide Ranked Number 21 in Deloittes Fast 50 Program for Greater Philadelphia
11. Accuray Incorporated Ranked Fifth in Deloittes Technology Fast 50 Program for Silicon Valley Scientific/Medical Equipment, and Biotechnology Companies

Post Your Comments:

(Date:12/5/2009)... Leukemia and myeloproliferative disorders are serious and often ... 51st Annual Meeting of the American Society of ... diagnostic methods for patients suffering from acute promyelocytic ... and myelofibrosis that are based on a better ...

(Date:12/5/2009)... Solutions, an innovative new international private medical insurance plan which follows ... offering customers the flexibility to add or remove a wide range ... customers to tailor their benefits to complement those already offered in ... ...

(Date:12/4/2009)... Inc. (NYSE: CRE ) ("Care" or the "Company") ... of $0.17 per share of common stock. The dividend is ... December 14, 2009. ,, About Care Investment ... investment and finance company investing in healthcare-related real estate and commercial ...

(Date:12/4/2009)... Association of Homes and Services for the Aging (AAHSA) applauds ... Supportive Services (CLASS) provisions remain in the final health reform ... to elders, people with disabilities and their caregivers. ,, ... bill that will make it affordable to care for families ...

(Date:12/4/2009)... Calif., Dec. 4 Pamela Bowen, Chief Information Officer ... the "Chief Innovation Officer" Appy Award for transforming Crescent,s ... recipients are nominated based on their innovative usage of ... levels of customer success to their sales, marketing, partner, ...

[0] Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders [0] AVIVA's Private Health Insurance Products Solutions Go International [0] Care Investment Trust Inc. Declares Quarterly Dividend of $0.17 Per Share [0] Statement from AAHSA CEO Larry Minnix on the Failure of the Thune Amendment [0] Crescent CIO '09 Dreamforce Conference Speaker and Award Finalist

... as cholera would take the heaviest toll on survivors ... camps has intensified// the spread of pneumonia, and health ... in the already devastated region. ,In the ... groups such as the World Health Organization issued statements ...

... A recent study shows , schizophrenics treated with ... risk for developing type 2 diabetes. Patients taking ... impairment of glucose effectiveness compared with patients taking ... non-obese people with schizophrenia or schizoaffective disorder who ...

... world is infected with tuberculosis every second and someone dies ... have discovered easier tests to detect this deadly disease in ... generally done with a gastric lavage. It's an invasive test ... a sputum sample. Sputum is what comes up when you ...

... for urinary tract infections also put them at risk for ... ,Researchers interviewed 242 women who were treated for kidney ... automated databases. They then compared data from these cases to ... history of kidney infections. ,Results of the study showed ...

... after a mastectomy does not reduce the long-term survival of ... had a better chance of survival than those who did ... may boost the morale and self-esteem of the patient, which ... implants could stimulate the immune system and reduce blood flow ...

... can help maintain cognitive skills in people as they ... For the study researchers reviewed data on 295 men ... and Netherlands Elderly (FINE) study. The length and intensity ... cognitive function was evaluated starting in 1990. ,Results ...

Other Medicine News:

Tsunami Survivors Face Pneumonia Threat Schizophrenics On Medication At An Increased Risk For Developing Diabetes Easier Tests To Detect Tuberculosis Identifying The Risk For Kidney Infection The Use Of Implants After Breast Cancer Questioned Physical Activity Good For Developing Cognitive Skills

(Date:12/4/2009)... 4 Hospira, Inc. (NYSE: HSP ), ... today announced the launch of its next-generation 50 mL ... and solutions, and now offers a complete size range ... responsible VisIV product. The launch of the 50 mL ...

(Date:12/4/2009)... developers of the AcceleDent System , which ... the availability of a new Continuing Education course ... in professional education for many industries, including medicine ... views about orthodontic treatment, a summary of treatment ...

(Date:12/4/2009)... 4 AstraZeneca (NYSE: AZN ) today ... has approved once-daily SEROQUEL XR® (quetiapine fumarate) Extended Release ... with Major Depressive Disorder (MDD). SEROQUEL XR is the ... to treat both major depressive disorder as adjunctive therapy ...

Breaking Medicine Technology:Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 2 Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 3 Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 4 AcceleDent Science is Showcased in New Continuing Education Course Published by PennWell 2 AcceleDent Science is Showcased in New Continuing Education Course Published by PennWell 3 AcceleDent Science is Showcased in New Continuing Education Course Published by PennWell 4 US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 2 US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 3 US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 4 US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 5 US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 6 US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 7 US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 8 US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 9 Football Pros in October Pink Gloves 58529 1 Football Pros in October Pink Gloves 58529 2 Intermountain McKay Dee Hospital Center Expands Real Time Locating Solution From Versus Technology Inc 5103 1 Intermountain McKay Dee Hospital Center Expands Real Time Locating Solution From Versus Technology Inc 5103 2 Intermountain McKay Dee Hospital Center Expands Real Time Locating Solution From Versus Technology Inc 5103 3 Breast Cancer Death Rates Continue to Drop 2 25 Annually 58525 1 Breast Cancer Death Rates Continue to Drop 2 25 Annually 58525 2 Breast Cancer Death Rates Continue to Drop 2 25 Annually 58525 3

[0] Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers [0] AcceleDent Science is Showcased in New Continuing Education Course Published by PennWell [0] US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder

... EMERYVILLE, Calif., Dec. 5 Neurobiological,Technologies, Inc. (Nasdaq: ... Holdings L.P. ("Celtic Pharma") presented interim results,for XERECEPT(R) ... Neuro-Oncology., Paul Freiman, President and Chief Executive ... continuing involvement in the development of XERECEPT,and the ...

... NEW YORK, Dec. 4 The Michael J. ... in total funding for five clinical research studies ... the Foundation,s focus on,accelerating scientific solutions that can ... initiative funds clinical research projects,with strong potential to ...

Other Medicine Technology:Celtic Pharma Provides Update on XERECEPT(R) Clinical Program 2 Celtic Pharma Provides Update on XERECEPT(R) Clinical Program 3 Celtic Pharma Provides Update on XERECEPT(R) Clinical Program 4 Five Clinical Studies to Receive $2.5 Million Under Foundation's 2007 Clinical Discovery Program 2 Five Clinical Studies to Receive $2.5 Million Under Foundation's 2007 Clinical Discovery Program 3

Celtic Pharma Provides Update on XERECEPT(R) Clinical Program Five Clinical Studies to Receive $2.5 Million Under Foundation's 2007 Clinical Discovery Program

... the Integrated Cytometry Solution offers a ... coupled with complete LIS connectivity. By ... sample undergoes - and managing the ... it delivers a progressive automated system ...

Convective Air Warming Blankets...

MAMMOMAT 3000 Nova supports high-volume screening as well as interventional diagnostics. Versatile procedural capabilities include magnification, stereotactic biopsy, needle localization, and specime...

Inquire...

Medicine Products:

Integrated Cytometry Solution FilteredFlo® Air Warming Blankets MAMMOMAT 3000 Nova Mammography System ActiveLife® One-Piece Cut-to-Fit Urostomy Pouch With Stomahesive® Skin Barrier

NxStage(R) Ranked 14th Fastest Growing Company in North America on Deloitte's 2008 Technolog...(ements to differ materially fromanticipa...),Health